Dong-A Socio Holdings Co., Ltd. (KRX:000640)

South Korea · Delayed Price · Currency is KRW

96,300

+4,100 (4.45%)

Last updated: Aug 28, 2026, 2:38 PM KST

-10.56% (1Y)

Market Cap	611.17B -14.4%
Revenue (ttm)	1.52T +10.1%
Net Income	85.25B -3.5%
EPS	12,783.76 -4.0%
Shares Out	6.63M
PE Ratio	7.21
Forward PE	7.36
Dividend	1,650.49 (1.81%)
Ex-Dividend Date	Jul 30, 2026

Volume	16,937
Open	90,700
Previous Close	92,200
Day's Range	90,700 - 96,800
52-Week Range	74,500 - 121,845
Beta	0.09
Analysts	Strong Buy
Price Target	145,000.00 (+50.57%)
Earnings Date	Oct 27, 2026

About Dong-A Socio Holdings

Dong-A Socio Holdings Co., Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea. It operates through Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments. The company develops DA-8010 in Phase 3 clinical trial to treat overactive bladder; DMB-3115, a biosimilar of Stelara in Phase 3 clinical trial; DA-1241 in Phase 2 clinical trial for the treatment of non-alcoholic steatohepatitis; DA-1726 in Phase 1 clinical tri... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1932

Employees 83

Stock Exchange Korea Stock Exchange

Ticker Symbol 000640

Full Company Profile

Financial Performance

In 2025, Dong-A Socio Holdings's revenue was 1.43 trillion, an increase of 7.24% compared to the previous year's 1.33 trillion. Earnings were 90.94 billion, an increase of 56.74%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 000640 stock is "Strong Buy." The 12-month stock price target is ₩145,000, which is an increase of 50.57% from the latest price.

Price Target

₩145,000

(50.57% upside)

Analyst Consensus: Strong Buy

Stock Forecasts